Home
EA Pharma

EA Pharma Market Share Analysis for November 2025

EAファーマの企業サイトです。ニュース、プレスリリース、お知らせ、更新履歴を掲載しております。

Health > Biotechnology and Pharmaceuticals

Domaineapharma.co.jp

Year Founded2016

Employees1001 - 5000

Annual Revenue$5M - $10M

EA Pharma

EA Pharma (including company regionals)

eapharma.co.jp

See more website traffic and engagement information

EA Pharma Revenue up to November 2025 is 5M - 10M

revenue generated by EA Pharma top domains

EA Pharma top domains revenue over 3 years

Revenue for EA Pharma top domains

eapharma.co.jp5M - 10M

See more with Sales Intelligence

Total visits to EA Pharma's top domains

Understand EA Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

eapharma.co.jp73.2K

See more with Sales Intelligence

Avg. visit duration in EA Pharma's top domains

Analyze EA Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

eapharma.co.jp00:01:06

See more with Sales Intelligence

Avg. pageviews on EA Pharma's top domains

See how EA Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

eapharma.co.jp2.23

See more with Sales Intelligence

EA Pharma top competitors by domain

Top similar sites in November 2025, ranked by their affinity

m3.comCompany NameM3Employees> 10001HQJapan, AkasakaAnnual revenue> $1BTotal visits5.5MHealth > Medicine

Top technologies used by EA Pharma

These are the website technologies, by industry, used by EA Pharma top domains

Advertising (5)

DoubleClick

Payment & Currencies (4)

Visa

Content Management System (3)

Drupal

Email Services (3)

Microsoft Exchange Online

More Technologies

8

See all

News & Signals from EA Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEA Pharma Co. invests into Newron Pharmaceuticals S.p.A. $123M.Under the terms of the agreement, Newron will receive up to €117 million from EA Pharma in exchange for full rights in the licensed territories.

NewsEnshorx partners with EA Pharma Co..Under the terms of the license agreement, in exchange for full commercialization rights in its territory, Ensho will conduct global clinical studies for EA1080, in collaboration with EA Pharma.

NewsEA Pharma Co. acquired Stardea s.r.l. on Jul 1st '22.Côte d'Azur-based EA Pharma is continuing its external growth operations with the acquisition of Italian company Stardea at the beginning of July 2022.